TARO PHARMACEUTICALS CANADA
Frank Laratta has extensive experience in quality control and assurance within the pharmaceutical industry, having served at TARO Pharmaceuticals Canada since July 1994. Throughout this tenure, Frank has held various roles, including Director of Quality Control, Senior Manager of Quality Control, and Manager of QC Compliance, among others, demonstrating a progressive career path. Prior to joining TARO, Frank worked as a QC Chemist at Ortho-McNeil Pharmaceutical from October 1993 to July 1994. Frank holds a Bachelor of Science degree in Biology and Chemistry from York University, earned between 1988 and 1993.
This person is not in any teams
TARO PHARMACEUTICALS CANADA
We are a global, research-driven, specialty pharmaceutical company. Established in 1950, Taro develops, manufactures and markets affordable prescription and over-the counter medications. With support from our parent company, Sun Pharma, the world's 5th largest specialty generic pharmaceutical company we are a powerful global presence. Our world class production facilities in Brampton, Ontario and nearly 600 Canadian employees give Taro Canada a uniquely Canadian perspective. Our Canadian focus on dermatology makes us a leading manufacturer and supplier of topical products such as creams, ointments, and gels. This investment in niche markets continues to differentiate Taro from our competitors. We specialize in generic prescription products, but also produce over the counter and brand name drugs. Our strong research program and niche strategy have positioned us as a central player in the specialty pharmaceutical sector.